What does APOTHEEK HEYLEN do?

APOTHEEK HEYLEN is a pharmacy in Nijlen. Private Limited, started on 12 March 1974, 1 establishment.

What is the address of APOTHEEK HEYLEN?

The registered office of APOTHEEK HEYLEN is located at Bouwelsesteenweg 7, 2560 Nijlen.

Is APOTHEEK HEYLEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK HEYLEN is active, legal situation “Normale toestand”, started on 12 March 1974.

Is APOTHEEK HEYLEN registered on Peppol?

Yes, APOTHEEK HEYLEN is registered on the Peppol network with ID 0208:0414011935.

What is the enterprise number of APOTHEEK HEYLEN?

The enterprise number of APOTHEEK HEYLEN is BE0414011935.

When was APOTHEEK HEYLEN founded?

APOTHEEK HEYLEN was founded on 12 March 1974.

Who are the directors of APOTHEEK HEYLEN?

According to the 2025 annual accounts, the directors of APOTHEEK HEYLEN are: JM Capital BV, Koekoek AVH BV, Collibri BV, Bart Heylen.

Is APOTHEEK HEYLEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 March 1974; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did APOTHEEK HEYLEN make in 2025?

APOTHEEK HEYLEN posted a profit after taxes of € 225,585 in financial year 2025.

What is the revenue of APOTHEEK HEYLEN?

As a small company, APOTHEEK HEYLEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 647,397.

How much does an employee at APOTHEEK HEYLEN earn?

The average wage cost per full-time employee at APOTHEEK HEYLEN was € 58,800 in 2025: staff costs of € 205,662 for 3.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK HEYLEN have?

According to the 2025 annual accounts, APOTHEEK HEYLEN has 3.5 full-time equivalents (FTE).

APOTHEEK HEYLEN (Private Limited) - Nijlen - BE0414011935

Dossier APOTHEEK HEYLEN, printed on 30 October 2026 from databakkes.be/en/0414011935/apotheek-heylen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK HEYLEN from Nijlen, company number BE0414011935, closed financial year 2025 with a result of € 225,585 after tax. For that financial year APOTHEEK HEYLEN recorded a gross margin of € 647,397 and equity of € 735,700. Compared with financial year 2024, the result moved from € 197,773 to € 225,585. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 735,700

▲ 44% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 225,585

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 366,225

▲ 81% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 717,108.

People and assets in 2025

Full-time equivalents

3.5

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 205,662

▼ 10% vs 2024

€ 58,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.3 million

▼ 8% vs 2024

€ 107,527 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 346,419

▲ 123% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 41,529

▲ 206% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 503,847 Gross margin 2022: € 503,847 First fiscal year in the series	€ 470,895 Gross margin 2023: € 470,895 ▼ 7% vs 2022 (€ 503,847) Unfavourable step	€ 560,506 Gross margin 2024: € 560,506 ▲ 19% vs 2023 (€ 470,895) Favourable step	€ 647,397 Gross margin 2025: € 647,397 ▲ 16% vs 2024 (€ 560,506) Favourable step	▲ 16%
Profit after taxes	€ 216,179 Profit after taxes 2022: € 216,179 First fiscal year in the series	€ 96,572 Profit after taxes 2023: € 96,572 ▼ 55% vs 2022 (€ 216,179) Unfavourable step	€ 197,773 Profit after taxes 2024: € 197,773 ▲ 105% vs 2023 (€ 96,572) Favourable step	€ 225,585 Profit after taxes 2025: € 225,585 ▲ 14% vs 2024 (€ 197,773) Favourable step	▲ 14%
Equity	€ 1,236,719 Equity 2022: € 1,236,719 First fiscal year in the series	€ 316,342 Equity 2023: € 316,342 ▼ 74% vs 2022 (€ 1,236,719) Unfavourable step	€ 510,115 Equity 2024: € 510,115 ▲ 61% vs 2023 (€ 316,342) Favourable step	€ 735,700 Equity 2025: € 735,700 ▲ 44% vs 2024 (€ 510,115) Favourable step	▲ 44%
Total debts	€ 1,077,190 Total debts 2022: € 1,077,190 First fiscal year in the series	€ 2,709,494 Total debts 2023: € 2,709,494 ▲ 152% vs 2022 (€ 1,077,190) Unfavourable step	€ 1,763,884 Total debts 2024: € 1,763,884 ▼ 35% vs 2023 (€ 2,709,494) Favourable step	€ 1,647,707 Total debts 2025: € 1,647,707 ▼ 7% vs 2024 (€ 1,763,884) Favourable step	▼ 7%
Cash	€ 107,586 Cash 2022: € 107,586 First fiscal year in the series	€ 87,387 Cash 2023: € 87,387 ▼ 19% vs 2022 (€ 107,586) Unfavourable step	€ 202,813 Cash 2024: € 202,813 ▲ 132% vs 2023 (€ 87,387) Favourable step	€ 366,225 Cash 2025: € 366,225 ▲ 81% vs 2024 (€ 202,813) Favourable step	▲ 81%
Land & buildings	€ 841,951 Land & buildings 2022: € 841,951 First fiscal year in the series	€ 825,122 Land & buildings 2023: € 825,122 ▼ 2% vs 2022 (€ 841,951) Unchanged	€ 808,292 Land & buildings 2024: € 808,292 ▼ 2% vs 2023 (€ 825,122) Unchanged	€ 791,463 Land & buildings 2025: € 791,463 ▼ 2% vs 2024 (€ 808,292) Unchanged	▼ 2%
Retained profit	€ 1,218,127 Retained profit 2022: € 1,218,127 First fiscal year in the series	€ 297,750 Retained profit 2023: € 297,750 ▼ 76% vs 2022 (€ 1,218,127) Unfavourable step	€ 491,523 Retained profit 2024: € 491,523 ▲ 65% vs 2023 (€ 297,750) Favourable step	€ 717,108 Retained profit 2025: € 717,108 ▲ 46% vs 2024 (€ 491,523) Favourable step	▲ 46%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,016,949 Dividend 2023: € 1,016,949 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,016,949) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 858,940 Bank debt 2022: € 858,940 First fiscal year in the series	€ 1,471,886 Bank debt 2023: € 1,471,886 ▲ 71% vs 2022 (€ 858,940) Unfavourable step	€ 1,361,767 Bank debt 2024: € 1,361,767 ▼ 7% vs 2023 (€ 1,471,886) Favourable step	€ 1,256,655 Bank debt 2025: € 1,256,655 ▼ 8% vs 2024 (€ 1,361,767) Favourable step	▼ 8%
Balance sheet total	€ 2,313,909 Balance sheet total 2022: € 2,313,909 First fiscal year in the series	€ 3,025,836 Balance sheet total 2023: € 3,025,836 ▲ 31% vs 2022 (€ 2,313,909) Unchanged	€ 2,273,999 Balance sheet total 2024: € 2,273,999 ▼ 25% vs 2023 (€ 3,025,836) Unchanged	€ 2,383,407 Balance sheet total 2025: € 2,383,407 ▲ 5% vs 2024 (€ 2,273,999) Unchanged	▲ 5%
Employees (FTE)	3.3 Employees (FTE) 2022: 3.3 First fiscal year in the series	3.6 Employees (FTE) 2023: 3.6 ▲ 0.3 vs 2022 (3.3) Unchanged	3.8 Employees (FTE) 2024: 3.8 ▲ 0.2 vs 2023 (3.6) Unchanged	3.5 Employees (FTE) 2025: 3.5 ▼ 0.3 vs 2024 (3.8) Unchanged	▼ 0.3

Key figures of APOTHEEK HEYLEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK HEYLEN?

What happened at APOTHEEK HEYLEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 225,585 (▲ 14% vs 2024). filed late Source: NBB ↗
2025 JM Capital BV became a director. NBB
2025 Koekoek AVH BV became a director. NBB
2025 Collibri BV became a director. NBB
2025 Bart Heylen stepped down as director. NBB
Apr 1, 1974 New establishment in Nijlen. KBO
Mar 12, 1974 Start of the company according to the CBE. KBO

In short

From € 216,179 profit in 2022 to € 225,585 profit in 2025.

Paid € 161,696 in corporate taxes since 2022.

Best year ever: 2025, with € 225,585 profit.

On average € 185,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

JM CAPITAL 100%

FARMA HEYLEN 98.3%

The stake of JM CAPITAL, FARMA HEYLEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK HEYLEN

Behind APOTHEEK HEYLEN are JM Capital BV, Koekoek AVH BV and Collibri BV. The shares are held by JM CAPITAL (100%) and FARMA HEYLEN (98.3%).

Directors

According to the 2025 annual accounts

JM Capital BV

Director · represented by Johan Van Hoof

Also active at: DERMATHEEK, Apotheek Van Hoecke, PJA Retail, P.J.A. BEHEER, APOTHEEK TANGHE, BEAUPHAR

since 2025

Koekoek AVH BV

Director · represented by Anouck Van Hoof

Also active at: DERMATHEEK, APOTHEEK DU FAUX, Apotheek Van Hoecke, APOTHEEK DU FAUX - MERELBEKE, PJA Retail, APOTHEEK TANGHE

since 2025

Collibri BV

Director · represented by Pieter-Jan Van Hoof

Also active at: DERMATHEEK, APOTHEEK DU FAUX, Apotheek Van Hoecke, APOTHEEK DU FAUX - MERELBEKE, PJA Retail, APOTHEEK TANGHE

since 2025

Bart Heylen

Director

Also active at: FARMA HEYLEN

· until 2025

Shareholders

JM CAPITAL

100%

FARMA HEYLEN

98.3%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Bouwelsesteenweg 7

2560 Nijlen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0414.011.935

VAT number

BE 0414.011.935

Registered office

Bouwelsesteenweg 7, 2560 Nijlen

Names & denominations

APOTHEEK HEYLEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 March 1974

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK HEYLEN

Financials

What happened to APOTHEEK HEYLEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions